Company Description

Aadi Bioscience, a KAKEN Pharmaceutical, is a commercial-stage biopharmaceutical company developing therapies for difficult to treat diseases. Aadi’s primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations, in which other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site.